PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.\', \'PEPperPRINT GmbH, R&D unit, Heidelberg, Germany.\', \'Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.\', \'Munich Clinic Schwabing, Academic Teaching Hospital, Ludwig-Maximilians University (LMU), Munich, Germany.\', \'German Centre for Infection Research, Associated Partner Charité, Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.629185
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33833755
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all